株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生分解性ステント:世界市場

Biodegradable Stents: Global Markets

発行 BCC Research 商品コード 819218
出版日 ページ情報 英文 102 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
生分解性ステント:世界市場 Biodegradable Stents: Global Markets
出版日: 2019年04月04日 ページ情報: 英文 102 Pages
概要

世界の生分解性ステント市場は2018年の1億680万米ドルからCAGR28.8%で拡大し、2023年までに3億7,800万米ドルに達すると予測されています。

当レポートでは、世界の生分解性ステント市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 市場と技術背景

  • 技術概要
  • 現在の金属製薬剤溶出ステントのアンメットニーズ
  • 後期でのステントの血栓と再狭窄
  • 永久的インプラント除去の影響
  • 技術背景
  • 生分解性ステントの技術的長所
  • 技術的欠点
  • 材料プラットフォームと分類
  • ポリマーステント
  • メタリックステント
  • 市場の規制
  • 促進因子
  • 成長する心血管インターベンション市場
  • 高齢化
  • 新興の中流階級
  • 高まる医療への意識
  • 主な課題
  • 法規制問題
  • コストの高い製品/手技
  • 安全性の問題
  • 移植のためのスキャッフォルド視覚化
  • 市場動向

第4章 用途別市場

  • 生分解性血管ステント
  • 冠動脈疾患用
  • 非冠動脈疾患用
  • 非血管疾患用
  • 尿管ステント
  • 消化管ステント
  • 胆管/膵臓ステント
  • 気管・気管支/肺ステント

第5章 地域別市場

  • 北米
  • アジア太平洋地域
  • 欧州
  • その他の諸国

第6章 特許レビュー

第7章 企業プロファイル

第8章 付録

図表

List of Tables

  • Summary Table: Global Market for Biodegradable Stents, by Region, Through 2023
    • Table 1: Properties of Biodegradable Materials Commonly Used in Biodegradable Stents
    • Table 2: Global Market for Biodegradable Stents for Vascular and Non-vascular Disease, Through 2023
    • Table 3: Global Market for Biodegradable Vascular Stents, Through 2023
    • Table 4: Global Market for Biodegradable Stents for Coronary and Non-coronary Vascular Disease, Through 2023
    • Table 5: Global Market for Biodegradable Stents for Coronary Disease, Through 2023
    • Table 6: CE-Marking-Approved Bioresorbable Scaffolds
    • Table 7: Global Market for Biodegradable Stents for Coronary Disease, by Region, Through 2023
    • Table 8: Other Biodegradable Stents in R&D
    • Table 9: Global Market for Biodegradable Stents for Non-coronary Vascular Disease, Through 2023
    • Table 10: Global Market for Biodegradable Stents for Non-coronary Vascular Disease, by Region, Through 2023
    • Table 11: Global Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
    • Table 12: Global Market for Biodegradable Stents for Peripheral Vascular Disease, by Type, Through 2023
    • Table 13: Global Market for Biodegradable Stents for Non-vascular Disease, Through 2023
    • Table 14: Global Market for Biodegradable Stents for Non-vascular Disease, by Region, Through 2023
    • Table 15: Global Market for Biodegradable Ureteral Stents, Through 2023
    • Table 16: Global Market for Gastrointestinal Biodegradable Stents, Through 2023
    • Table 17: Global Market for Biliary/Pancreatic Biodegradable Stents, Through 2023
    • Table 18: Global Market for Biodegradable Stents, by Region, Through 2023
    • Table 19: North American Market for Biodegradable Stents, Through 2023
    • Table 20: North American Market for Biodegradable Stents for Vascular Disease, Through 2023
    • Table 21: U.S. Market for Biodegradable Stents, Through 2023
    • Table 22: U.S. Market for Biodegradable Stents for Vascular Disease, Through 2023
    • Table 23: U.S. Market for Biodegradable Stents for Coronary Disease, Through 2023
    • Table 24: U.S. Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
    • Table 25: U.S. Market for Biodegradable Stents for Other Non-coronary Vascular (Carotid) Diseases, Through 2023
    • Table 26: U.S. Market for Biodegradable Stents for Non-vascular Disease, Through 2023
    • Table 27: APAC Market for Biodegradable Stents, Through 2023
    • Table 28: APAC Market for Biodegradable Stents for Coronary Disease, Through 2023
    • Table 29: APAC Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
    • Table 30: APAC Market for Biodegradable Stents for Other Non-coronary Vascular (Carotid) Diseases, Through 2023
    • Table 31: APAC Market for Biodegradable Stents for Vascular Disease, Through 2023
    • Table 32: APAC Market for Biodegradable Stents for Non-vascular Disease, Through 2023
    • Table 33: Indian Market for Biodegradable Stents, Through 2023
    • Table 34: Number of Coronary Stents Implanted in India, Through 2017
    • Table 35: European Union Market for Biodegradable Stents, Through 2023
    • Table 36: European Union Market for Biodegradable Stents for Coronary Disease, Through 2023
    • Table 37: European Union Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
    • Table 38: European Union Market for Biodegradable Stents for Non-coronary Vascular Disease, Through 2023
    • Table 39: European Union Market for Biodegradable Stents for Vascular Disease, Through 2023
    • Table 40: European Union Market for Biodegradable Stents for Non-vascular Disease, Through 2023
    • Table 41: ROW Market for Biodegradable Stents, Through 2023
    • Table 42: ROW Market for Coronary Biodegradable Stents, Through 2023
    • Table 43: ROW Market for Biodegradable Stents for Peripheral Artery Disease, Through 2023
    • Table 44: ROW Market for Biodegradable Stents for Non-coronary Vascular Disease, Through 2023
    • Table 45: ROW Market for Biodegradable Stents for Vascular Disease, Through 2023
    • Table 46: ROW Market for Biodegradable Stents for Non-vascular Disease, Through 2023
    • Table 47: ROW Market for Biodegradable Stents, by Country, Through 2023
    • Table 48: Patents and Patent Applications on Biodegradable Stents, Through 2018
    • Table 49: Abbott Laboratories: Company Financials, Through 2017
    • Table 50: Boston Scientific Corp.: Company Financials, Through 2017
    • Table 51: Lepu Medical Corp.: Company Financials, Through 2017
    • Table 52: Lifetech Scientific Corp.: Company Financials, Through 2017
    • Table 53: Microport Scientific Corp.: Company Financials, Through 2017
    • Table 54: Stentys S.A.: Company Financials, Through 2017
    • Table 55: Acronyms Used in the Biodegradable Stents Industry
    • Table 56: Glossary of Terms Used in the Biodegradable Stents Industry

List of Figures

  • Summary Figure: Global Market for Biodegradable Stents, by Region, 2016-2023
    • Figure 1: Global Market Shares of Biomaterials Used in Biodegradable Stents, by Type, 2016
    • Figure 2: Global Market Shares of Biomaterials Used in Biodegradable Stents, by Type of Material, 2023
    • Figure 3: Global Market for Biodegradable Stents for Cardiovascular Disease, by Region, 2018-2023
    • Figure 4: Forecast Global Population Share, by Age Group, 2050
    • Figure 5: Global Market Shares of Biodegradable Stents for Vascular and Non-vascular Disease, 2018
    • Figure 6: Global Market Shares of Biodegradable Stents for Vascular and Non-vascular Disease, 2023
    • Figure 7: Global Market Shares of Biodegradable Stents for Coronary and Non-coronary Vascular Disease, 2018
    • Figure 8: Global Market Shares of Biodegradable Stents Coronary and Non-coronary Vascular Disease, 2023
    • Figure 9: Global Market Penetration of Biodegradable Stents for Peripheral Vascular Disease, by Type, 2016-2023
    • Figure 10: Global Market Shares of Biodegradable Stents for Peripheral Vascular Disease, by Type, 2023
    • Figure 11: Global Market Shares of Biodegradable Stents for Non-vascular Disease, by Type, 2018
    • Figure 12: Global Market Shares of Biodegradable Stents for Non-vascular Disease, by Type, 2023
    • Figure 13: Global Market Shares of Biodegradable Stents, by Region, 2018
    • Figure 14: Global Market Shares of Biodegradable Stents, by Region, 2023
    • Figure 15: North American Market Shares of Biodegradable Stents, by Application, 2023
    • Figure 16: APAC Market Shares of Biodegradable Stents, by Application, 2023
    • Figure 17: Indian Market Volume Shares of Stents, by Type, 2016
    • Figure 18: European Union Market Shares of Biodegradable Stents, by Disease Application, 2023
    • Figure 19: ROW Market Shares of Biodegradable Stents, by Application, 2023
    • Figure 20: Number of Patents on Biodegradable Stents, 2012-2017
    • Figure 21: Global Market Shares of Patents on Biodegradable Stents, by Country, 2012-2017
    • Figure 22: Global Patents on Biodegradable Stents Published by Top Patents Offices, 2015-2017
    • Figure 23: Patents Granted to Assignees with at Least Five Patents on Biodegradable Stents, 2012-2017
    • Figure 24: Global Market Shares of Patents on Biodegradable Stents, by Application, 2012-2017
目次
Product Code: AVM158A

Report Highlights:

The global market for biodegradable stents should grow from $106.7 million in 2018 to $378.0 million by 2023 with a compound annual growth rate (CAGR) of 28.8% for the period of 2018-2023.

The European Union (EU) market for biodegradable stents should grow from $82.3 million in 2018 to $165.4 million by 2023 with a CAGR of 15.0% for the period of 2018-2023.

The Asia-Pacific market for biodegradable stents should grow from $20.4 million in 2018 to $108.4 million by 2023 with a CAGR of 39.7% for the period of 2018-2023.

Report Scope:

This report reviews both global and regional markets of the biodegradable stents market according to available types and application areas. The report analyzes the current market status and trends, and provides growth forecasts for the five-year period 2018 to 2023. The analysis also discusses R&D issues, including global regulatory scenarios and other commercialization hurdles. Additionally, this comprehensive report examines technology developers/manufacturers of biodegradable stents, their product types and geographical product presence (wherever data is available).

The biodegradable stents market is divided into the following types -

  • Polymer-based.
  • Metal-based.

The report differentiates BDS from conventional metallic DES that have a matrix coating of bioresorbable polymer and antiproliferative drug. These devices, which have typical metallic nondegradable stent backbones, are known as bioresorbable polymer DES, bioabsorbable polymer DES or biodegradable polymer DES. Therefore, this report concentrates only on the BDS market for fully bioabsorbable or biodegradable stents.

The only applications of the biodegradable stent market that have been analyzed in this report includes -

  • BDS for vascular disease.
  • Coronary BDS.
  • Non-coronary vascular BDS.
  • BDS for non-vascular disease.
  • Ureteral.
  • Gastrointestinal.
  • Biliary.
  • Pancreatic.
  • Others.

The report also offers a detailed patent analysis with information on the strategic initiatives of market players within the past five years.

The report specifically excludes stents that are not fully biodegradable and also stents that have bioabsorbable coatings which are not fully bioabsorbable. The report also excludes biomaterial technology/product and equipment providers.

Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Technology Overview
  • Unmet Needs of Current Metallic DES
    • Very Late Stent Thrombosis and Restenosis
    • Implications of the Removal of a Permanent Implant
  • Technology Background
    • Technological Advantages of Biodegradable Stents
    • Technological Disadvantages
  • BDS Material Platform and Classification
    • Polymeric Biodegradable Stents
    • Metallic Biodegradable Stents
  • Market Regulation
  • Key Drivers
    • Growing Cardiovascular Intervention Market
    • Aging Populations
    • Emerging Middle Class
    • Increased Health Awareness
  • Key Challenges
    • Regulatory Issues
    • High Cost of Products/Procedure
    • Safety Issues
    • Visualization of the Scaffold for Implantation
    • Scaffold Deliverability
    • Scaffold Implantation
    • Radial Strength
    • Low Ductility
  • Market Trends

Chapter 4: Market Breakdown by Application Type

  • Biodegradable Vascular Stents (BVS)
    • Biodegradable Stents for Coronary Disease
    • Biodegradable Stents for Non-coronary Vascular Disease
  • BDS for Non-vascular Disease
    • Ureteral Stents
    • Gastrointestinal Stents
    • Bile Duct/Pancreatic Stents
    • Tracheobronchial/Pulmonary Stents

Chapter 5: Market Breakdown by Region

  • North America
    • U.S.
  • APAC
    • India
    • China
  • European Union
  • ROW
    • Brazil

Chapter 6: Patent Review

  • Patent Review by Year
  • Patent Review by Country
  • Patent Review by Assignee
  • Patent Review by Application

Chapter 7: Company Profiles

  • ABBOTT VASCULAR INC.
  • AKINA INC.
  • AMARANTH MEDICAL INC.
  • AMG INTERNATIONAL GMBH
  • ARTERIAL REMODELING TECHNOLOGIES S.A. (ART)
  • ARTERIUS LTD.
  • BIOTRONIK INC.
  • BOSTON SCIENTIFIC CORP.
  • CARDIONOVUM GMBH
  • ELIXIR MEDICAL CORP.
  • ELLA-CS S.R.O.
  • ENDOCOR GMBH
  • HYDRUSTENT
  • KYOTO MEDICAL PLANNING CO. LTD.
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
  • LIFETECH SCIENTIFIC CORP.
  • LYRA THERAPEUTICS
  • MERIL LIFE SCIENCES
  • MICELL TECHNOLOGIES INC.
  • MICROPORT SCIENTIFIC CORP.
  • REVA MEDICAL INC.
  • S3V VASCULAR TECHNOLOGIES
  • SAHAJANAND MEDICAL TECHNOLOGIES (SMT)
  • SINO MEDICAL SCIENCES TECHNOLOGY INC. (SINOMED)
  • STENTYS S.A.
  • TEPHA INC.
  • TERUMO CARDIOVASCULAR SYSTEMS CORP.
  • ZORION MEDICAL INC.

Chapter 8: Appendix

  • Acronyms
  • Glossary
  • Countries That Require CE Marking
Back to Top